Together, our findings suggest that H. pylori and activation of EGF/HER2 signaling increase the aggressiveness of GC and are consistent with recent clinical data indicating that H. pylori eradication could provide long-term survival advantage for GC patients. Here, ERBB2 is linked to gastric cancer.